Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


15.05.2017

2 AIDS
1 Ann Intern Med
1 BMC Gastroenterol
1 Cancer
2 Drugs
1 Eur J Gastroenterol Hepatol
1 Gut
2 Hepatology
1 Int J STD AIDS
1 J Clin Gastroenterol
1 J Hepatol
3 J Med Virol
1 J Pediatr
4 J Viral Hepat
1 J Virol
1 Lancet Gastroenterol Hepatol
2 Lancet Glob Health
2 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
5 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. TODESCO E, Demeret S, Calin R, Roque-Afonso AM, et al
    Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
    AIDS. 2017;31:1346-1348.
    PubMed     Text format    

  2. GRIESBECK M, Valantin MA, Lacombe K, Samri-Hassimi A, et al
    Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    AIDS. 2017;31:1223-1234.
    PubMed     Text format     Abstract available


    Ann Intern Med

  3. LY KN, Jiles RB, Teshale EH, Foster MA, et al
    Hepatitis C Virus Infection Among Reproductive-Aged Women and Children in the United States, 2006 to 2014.
    Ann Intern Med. 2017 May 9. doi: 10.7326/M16-2350.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  4. XU H, Kong W, Liu L, Chi X, et al
    Accuracy of M2BPGi, compared with Fibro Scan(R), in analysis of liver fibrosis in patients with hepatitis C.
    BMC Gastroenterol. 2017;17:62.
    PubMed     Text format     Abstract available


    Cancer

  5. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Text format     Abstract available


    Drugs

  6. BAGAGLIO S, Uberti-Foppa C, Morsica G
    Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.
    Drugs. 2017 May 12. doi: 10.1007/s40265-017-0753.
    PubMed     Text format     Abstract available

  7. SCOTT LJ, Chan HLY
    Tenofovir Alafenamide: A Review in Chronic Hepatitis B.
    Drugs. 2017 May 11. doi: 10.1007/s40265-017-0754.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  8. JABLONKA A, Solbach P, Wobse M, Manns MP, et al
    Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.
    Eur J Gastroenterol Hepatol. 2017 May 10. doi: 10.1097/MEG.0000000000000889.
    PubMed     Text format     Abstract available


    Gut

  9. THOMAS E
    Hepatitis B virus X protein: TRIMming antiviral defences in hepatocytes.
    Gut. 2017 May 5. pii: gutjnl-2017-314013. doi: 10.1136/gutjnl-2017-314013.
    PubMed     Text format    


    Hepatology

  10. GANE EJ, Shiffman ML, Etzkorn K, Morelli G, et al
    Sofosbuvir-velpatasvir with ribavirin for 24 weeks in HCV patients previously treated with a direct-acting antiviral regimen.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29256.
    PubMed     Text format     Abstract available

  11. WANG CC, Kao JH
    Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
    Hepatology. 2017 May 8. doi: 10.1002/hep.29252.
    PubMed     Text format    


    Int J STD AIDS

  12. VET R, de Wit JB, Das E
    Factors associated with hepatitis B vaccination among men who have sex with men: a systematic review of published research.
    Int J STD AIDS. 2017;28:534-542.
    PubMed     Text format     Abstract available


    J Clin Gastroenterol

  13. KUSHNER T, Lam R, Gray DL, Kaplan DE, et al
    Identifying Patient and Provider-specific Gaps in Care Among Patients With Hepatitis B.
    J Clin Gastroenterol. 2017 May 10. doi: 10.1097/MCG.0000000000000806.
    PubMed     Text format     Abstract available


    J Hepatol

  14. COLPITTS CC, Baumert TF
    SCARB1 variants and HCV infection: Host susceptibility is lost in translation.
    J Hepatol. 2017 May 3. pii: S0168-8278(17)30255.
    PubMed     Text format    


    J Med Virol

  15. RAZIKY ME, Zayed NA, Baki AA, Mansour SA, et al
    ITPA Gene polymorphism (94C>A) Effects on Ribavirin-Induced Anemia during Therapy in Egyptian Patients with Chronic Hepatitis C.
    J Med Virol. 2017 May 8. doi: 10.1002/jmv.24844.
    PubMed     Text format     Abstract available

  16. HUDSON B, Walker AJ, Irving WL
    Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK.
    J Med Virol. 2017 May 8. doi: 10.1002/jmv.24848.
    PubMed     Text format     Abstract available

  17. KAR P, Kumar D, Gumma PK, Chowdhury SJ, et al
    Down regulation of TRIF, TLR3 and MAVS in HCV infected liver correlates with the outcome of infection.
    J Med Virol. 2017 May 8. doi: 10.1002/jmv.24849.
    PubMed     Text format     Abstract available


    J Pediatr

  18. CASILLAS SM, Bednarczyk RA
    Missed Opportunities for Hepatitis A Vaccination, National Immunization Survey-Child, 2013.
    J Pediatr. 2017 May 5. pii: S0022-3476(17)30484.
    PubMed     Text format     Abstract available


    J Viral Hepat

  19. HLAING NKT, Mitrani RA, Aung ST, Phyo WW, et al
    Safety and Efficacy of Sofosbuvir-Based DAA Regimens for Hepatitis C Virus Genotypes 1 - 4 and 6 in Myanmar: Real-world experience.
    J Viral Hepat. 2017 May 5. doi: 10.1111/jvh.12721.
    PubMed     Text format     Abstract available

  20. SHAWA IT, Felmlee DJ, Hegazy D, Sheridan DA, et al
    Exploration of potential mechanisms of HCV resistance in exposed uninfected intravenous drug users.
    J Viral Hepat. 2017 May 5. doi: 10.1111/jvh.12720.
    PubMed     Text format     Abstract available

  21. WEDEMEYER H, Craxi A, Zuckerman E, Dieterich D, et al
    Real-World Effectiveness of Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir +/- Ribavirin in Patients with HCV Genotype 1 or 4 Infection: a Meta-Analysis.
    J Viral Hepat. 2017 May 8. doi: 10.1111/jvh.12722.
    PubMed     Text format     Abstract available

  22. KIM GA, Han S, Kim HD, An J, et al
    Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis B vs Chronic Hepatitis C after Achievement of Virologic Response.
    J Viral Hepat. 2017 May 12. doi: 10.1111/jvh.12723.
    PubMed     Text format     Abstract available


    J Virol

  23. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  24. PETTA S, Marzioni M, Russo P, Aghemo A, et al
    Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.
    Lancet Gastroenterol Hepatol. 2017;2:427-434.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  25. HUANG QT, Zhong M
    Maternal hepatitis B virus infection and risk of preterm birth in China.
    Lancet Glob Health. 2017;5:e563-e564.
    PubMed     Text format    

  26. LIU J, Zhang S, Liu M, Wang Q, et al
    Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study.
    Lancet Glob Health. 2017;5:e624-e632.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  27. CAMPBELL CA, Canary L, Smith N, Teshale E, et al
    State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs - United States, 2015-2016.
    MMWR Morb Mortal Wkly Rep. 2017;66:465-469.
    PubMed     Text format     Abstract available

  28. PATRICK SW, Bauer AM, Warren MD, Jones TF, et al
    Hepatitis C Virus Infection Among Women Giving Birth - Tennessee and United States, 2009-2014.
    MMWR Morb Mortal Wkly Rep. 2017;66:470-473.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  29. BASSAL R, Weil M, Cohen D, Sofer D, et al
    Seroprevalence of Hepatitis A 12-years Following the Implementation of Toddlers' Vaccination: A Population Based Study in Israel.
    Pediatr Infect Dis J. 2017 May 11. doi: 10.1097/INF.0000000000001640.
    PubMed     Text format     Abstract available


    PLoS One

  30. WASITTHANKASEM R, Vichaiwattana P, Siripon N, Posuwan N, et al
    Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
    PLoS One. 2017;12:e0177022.
    PubMed     Text format     Abstract available

  31. NAKAMURA M, Kanda T, Jiang X, Haga Y, et al
    Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    PLoS One. 2017;12:e0177302.
    PubMed     Text format     Abstract available

  32. CHANG CC, Hsu HJ, Yen JH, Lo SY, et al
    A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.
    PLoS One. 2017;12:e0177383.
    PubMed     Text format     Abstract available

  33. PANDOLFI R, Ramos de Almeida D, Alves Pinto M, Kreutz LC, et al
    In house ELISA based on recombinant ORF2 protein underline high prevalence of IgG anti-hepatitis E virus amongst blood donors in south Brazil.
    PLoS One. 2017;12:e0176409.
    PubMed     Text format     Abstract available

  34. BIRGER RB, Le T, Kouyos RD, Grenfell BT, et al
    The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam.
    PLoS One. 2017;12:e0177195.
    PubMed     Text format     Abstract available


    PLoS Pathog

  35. ONO C, Fukuhara T, Motooka D, Nakamura S, et al
    Characterization of miR-122-independent propagation of HCV.
    PLoS Pathog. 2017;13:e1006374.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  36. MCKNIGHT KL, Xie L, Gonzalez-Lopez O, Rivera-Serrano EE, et al
    Protein composition of the hepatitis A virus quasi-envelope.
    Proc Natl Acad Sci U S A. 2017 May 10. pii: 201619519.
    PubMed     Text format     Abstract available


    Vaccine

  37. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: